Bio
Dr. Plante obtained her medical degree from Laval University in 1985 and completed her residency in obstetrics and gynecology at McGill University in 1990. She continued with a 3-year subspecialty in gynecologic oncology at the Memorial Sloan-Kettering Cancer Center in New York in 1993. Since then, she has worked as a gynecologist-oncologist at l’Hôtel-Dieu de Québec.
Dr. Plante is a Professor in the Department of Obstetrics and Gynecology at Laval University. She is head of the oncology-gynecology department and in charge of clinical research at l’Hôtel-Dieu de Québec.
Expertise
- Plante is best known for her expertise in minimally invasive surgery in the treatment of gynecological cancers, including robot-assisted surgery, the sentinel lymph node technique in gynecological cancers and in surgeries aimed at preserving fertility in young women suffering from cervical cancer, including radical trachelectomy.
- Plante is the principal investigator of a large international, prospective and randomized study led by the Canadian Cancer Trials Group (CCTG) and the Gynecologic Cancer InterGroup (GCIG) (CX-5 or SHAPE study). The study aims to randomize patients with early-stage and low-risk cervical cancer to receive either radical hysterectomy (standard) or simple hysterectomy (studied). More than 700 patients will be randomized in this study.
- In addition, Dr. Plante is particularly interested in oncogenetics related to ovarian cancer. She has been involved in the activities of the oncogenetics department, along with the St-Sacrement Hospital team, since its inception, and is responsible for its ovarian component.
Recent Appointments
- Co-chair of CCRN (Cervical Cancer Research Network)
- Chair, International Committee, SGO (Society of Gynecologic Oncology)
- Co-chair, Cervix Working Group, CCTG
- Member, Editorial Board, International Journal of Gynecologic Cancer (IJGC) and Journal of Obstetrics and Gynecology of Canada (JOGC)
11, côte du Palais
Québec, Québec
Canada G1R 2J6
Latest news
Data not available
Comparison of outcomes between abdominal, minimally invasive and combined vaginal-laparoscopic hysterectomy in patients with stage IAI/IA2 cervical cancer: 4C (Canadian Cervical Cancer Collaborative) study
Journal ArticleGynecol Oncol, 2022.
Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases
Journal ArticleGynecol Oncol, 165 (2), 2022.
Variation in practice in endometrial cancer and potential for improved care and equity through molecular classification
Journal ArticleGynecol Oncol, 165 (2), 2022.
Minimally Invasive Surgery for Cervical Cancer in Light of the LACC Trial: What Have We Learned?
Journal ArticleCurr Oncol, 29 (2), 2022.
Five-Year Experience in the Surgical Treatment of Endometrial Cancer: Comparing Laparotomy with Robotic and Minimally Invasive Hysterectomy
Journal ArticleJ Obstet Gynaecol Can, 44 (1), 2022.
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study
Journal ArticleAnaesthesia, 76 (11), 2021.
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study
Journal ArticleAnaesthesia, 76 (6), 2021.
An in-home rehabilitation program for the treatment of urinary incontinence symptoms in endometrial cancer survivors: a single-case experimental design study
Journal ArticleInt Urogynecol J, 32 (11), 2021.
High-grade endometrial carcinoma limited to the endometrium or a polyp: is adjuvant treatment necessary?
Journal ArticleInt J Gynecol Cancer, 31 (10), 2021.
In Memoriam: Dr Michel Roy
Journal ArticleInt J Gynecol Cancer, 31 (9), 2021.